Epigenetics in atherosclerosis: key features and therapeutic implications.

Gail B. Mahady, S. L. Pendland, G. Yun, Z. Z. Lu, Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Research. ,vol. 22, pp. 4179- 4181 ,(2002)

Eric Winquist, Jennifer Knox, Jean-Pierre Ayoub, Lori Wood, Nancy Wainman, Gregory K. Reid, Laura Pearce, Ajit Shah, Elizabeth Eisenhauer, Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study Investigational New Drugs. ,vol. 24, pp. 159- 167 ,(2006) , 10.1007/S10637-006-5938-1

Stephen J. Nicholls, Allan Gordon, Jan Johannson, Christie M. Ballantyne, Philip J. Barter, H. Bryan Brewer, John J. P. Kastelein, Norman C. Wong, Marilyn R. N. Borgman, Steven E. Nissen, ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies Cardiovascular Drugs and Therapy. ,vol. 26, pp. 181- 187 ,(2012) , 10.1007/S10557-012-6373-5

Panagis Filippakopoulos, Stefan Knapp, Targeting bromodomains: epigenetic readers of lysine acetylation Nature Reviews Drug Discovery. ,vol. 13, pp. 337- 356 ,(2014) , 10.1038/NRD4286

Louis V. LaFrance, Mark Mellinger, Celine Duquenne, Xinrong Tian, Ryan G. Kruger, Charles F. McHugh, Martin Brandt, William H. Miller, Dashyant Dhanak, Sharad K. Verma, Peter J. Tummino, Caretha L. Creasy, Michael T. McCabe, Heidi M. Ott, Gopinath Ganji, Susan Korenchuk, Christine Thompson, Glenn S. Van Aller, Yan Liu, Alan P. Graves, Anthony Della Pietra III, Elsie Diaz, EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. ,vol. 492, pp. 108- 112 ,(2012) , 10.1038/NATURE11606

Bin Zheng, Mei Han, Ya-nan Shu, Ying-jie Li, Sui-bing Miao, Xin-hua Zhang, Hui-jing Shi, Tian Zhang, Jin-kun Wen, HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs Cell Research. ,vol. 21, pp. 1487- 1508 ,(2011) , 10.1038/CR.2011.34

E. Aavik, H. Lumivuori, O. Leppanen, T. Wirth, S.-K. Hakkinen, J.-H. Brasen, U. Beschorner, T. Zeller, M. Braspenning, W. van Criekinge, K. Makinen, S. Yla-Herttuala, Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster. European Heart Journal. ,vol. 36, pp. 993- 1000 ,(2015) , 10.1093/EURHEARTJ/EHU437

Morgan Salmon, Delphine Gomez, Elizabeth Greene, Laura Shankman, Gary K. Owens, Cooperative Binding of KLF4, pELK-1, and HDAC2 to a G/C Repressor Element in the SM22α Promoter Mediates Transcriptional Silencing During SMC Phenotypic Switching In Vivo Circulation Research. ,vol. 111, pp. 685- 696 ,(2012) , 10.1161/CIRCRESAHA.112.269811

Ravi Jahagirdar, Haiyan Zhang, Salman Azhar, Jennifer Tobin, Sarah Attwell, Raymond Yu, Jin Wu, Kevin G. McLure, Henrik C. Hansen, Gregory S. Wagner, Peter R. Young, Rai Ajit K. Srivastava, Norman C.W. Wong, Jan Johansson, A Novel BET Bromodomain Inhibitor, RVX-208, Shows Reduction of Atherosclerosis in Hyperlipidemic ApoE Deficient Mice Atherosclerosis. ,vol. 236, pp. 91- 100 ,(2014) , 10.1016/J.ATHEROSCLEROSIS.2014.06.008

Yun-Cheng Lv, Yan-Yan Tang, Ping Zhang, Wei Wan, Feng Yao, Ping-Ping He, Wei Xie, Zhong-Cheng Mo, Jin-Feng Shi, Jian-Feng Wu, Juan Peng, Dan Liu, Francisco S. Cayabyab, Xi-Long Zheng, Xiang-Yang Tang, Xin-Ping Ouyang, Chao-Ke Tang, Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis PLOS ONE. ,vol. 11, pp. e0157265- ,(2016) , 10.1371/JOURNAL.PONE.0157265